Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Neurescue International ApS
APS
Active
CVR 43257722
Antonigade 11, 2.
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2022
— employees
www.neurescue.com
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK -16K
-102% vs 2023
EBITDA margin
100.0%
-102% vs 2023
Equity ratio
97.1%
Financial strength
Net profit 2024
DKK -16K
-103% vs 2023
EBITDA — year on year
DKK millions
1M
1M
1M
0M
0M
0M
2022
1M
+100%
2023
0M
-100%
2024
Key figures
Annual report 2024
Revenue
DKK -16K
-102%
EBITDA
DKK -16K
-102%
Net profit
DKK -16K
-103%
Total assets
DKK 547K
-23%
Equity
DKK 532K
-3%
Employees
—
—
Company information
Legal name
Neurescue International ApS
CVR number
43257722
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
12. maj 2022
Share capital
DKK 40.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen.
Company purpose
Selskabets formål er at sælge medicinsk udstyr samt hermed beslægtet virksomhed.
Contact
Address
Antonigade 11, 2.
Website
www.neurescue.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in København
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2022
1M
2023
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2022
1M
2023
0M
2024
Income statement
DKK thousands
Item
2022
2023
2024
Revenue
0
663
-16
Staff expenses
-0
-0
-0
EBITDA
-13
663
-16
Depreciation & amort.
-0
-0
-0
EBIT
-13
663
-16
Net financials
0
0
0
Profit before tax
-13
663
-16
Tax
-0
143
-0
Net profit
-13
520
-16
Balance sheet
DKK thousands
Item
2022
2023
2024
Total assets
34
706
547
Equity
27
548
532
Long-term debt
0
0
0
Short-term debt
6
159
16
Total debt
6
159
16
Financial ratios
5-year trend
EBITDA margin
-1600000.0%
This company
15.8%
Market median
-10126682% vs market
2022
2024
Equity ratio
97.1%
This company
38.2%
Market median
+154% vs market
2022
2024
Return on equity
-3.0%
This company
18.4%
Market median
-116% vs market
2022
2024
Net profit margin
-1600000.0%
This company
8.1%
Market median
-19753186% vs market
2022
2024
Asset turnover
-0.03×
This company
1.12×
Market median
-103% vs market
2022
2024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-05-12 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
HF
Habib Frost
Management
Management
2022
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
NEURESCUE ApS
Company
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
NEURESCUE ApS
Neurescue International ApS
(this company)
Board network connections
Board members of Neurescue International ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Habib Frost
Management
0 companies